Opening Bell Analysts Research Calls for Friday, March 17

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here.  Upgrades: > Columbia Banking (COLB) upgraded to Overweight from Neutral at Piper Sandler; tgt $32 > Dr. Reddy’s (RDY) upgraded to Buy…

Published March 17, 2023, 9:41am ET · 1 min read

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Research calls posted earlier this morning are available here

Upgrades:

> Columbia Banking (COLB) upgraded to Overweight from Neutral at Piper Sandler; tgt $32

> Dr. Reddy’s (RDY) upgraded to Buy from Neutral at BofA Securities

> SAP SE (SAP) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $143

Downgrades:

> Bath & Body Works (BBWI) downgraded to Hold from Buy at Argus

> First Republic Bank (FRC) downgraded to Neutral from Overweight at Argus

> Konami Holdings (KNMCY) downgraded to Underperform from Buy at CLSA

> Sage plc (SGPYY) downgraded to Neutral from Outperform at Exane BNP Paribas

> Xero (XROLF) downgraded to Outperform from Buy at CLSA

Others:

> Autolus Therapeutics (AUTL) initiated with a Buy at Bryan Garnier; tgt $5

> Cellectis (CLLS) initiated with a Buy at Bryan Garnier; tgt $6

> CRISPR Therapeutics (CRSP) initiated with a Buy at Bryan Garnier; tgt $70

> FactSet (FDS) initiated with an Outperform at CICC; tgt $500

Contact [email protected] for any questions or corrections.

Paul Ausick

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

All articles →